Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 7 – 10 July 2025 15 July 2025 PharmacovigilanceSafety Announcements 15 Jul 2025
Ministerial Decision on the Electronic Distribution of Educational Materials. 3 July 2025 Legal framework 03 Jul 2025
Amendment and supplementation of DYG3a/G.P. 32221/29−4−2013 J.M.A. 3 July 2025 Legal framework 03 Jul 2025
Harmonization of Greek Legislation with the corresponding Community legislation 3 July 2025 Legal framework 03 Jul 2025
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 2 – 5 June 2025 June 16 2025 PharmacovigilanceSafety Announcements June 16, 2025
Semaglutide treatment should be discontinued if NAION occurs. June 16 2025 PharmacovigilanceSafety Announcements June 16, 2025
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 5-8 May 2025 19 May 2025 Pharmacovigilance 19 May 2025
Measures to minimize the risk of suicidal ideation with finasteride and dutasteride 14 May 2025 Pharmacovigilance 14 May 2025
END OF PILOT PERIOD FOR ELECTRONIC AND PAPER DISTRIBUTION OF EDUCATIONAL MATERIALS April 16 2025 PharmacovigilanceManufacturingUncategorizedAnnouncements 16 Apr 2025
